Pharma, biopharma, and medical device makers should watch out for these perennial problems, which include inadequate ...
The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...
GlobalData on MSN1d
FDA protocol deviation guidance could go furtherThe US Food and Drug Administration has released draft guidance on protocol deviations, but experts say it could go further.
With the FDA quietly rolling back DEI initiatives under Trump’s latest executive order, experts warn that underrepresentation ...
In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback